Results 171 to 180 of about 2,680 (197)
Some of the next articles are maybe not open access.
Use of Eravacycline for Acinetobacter baumannii Infections: A Case Series
Journal of Pharmacy Practice, 2023This case series describes the clinical course of 10 patients who received eravacycline antimicrobial therapy for a variety of different Acinetobacter baumannii infection types at a community care hospital.
Valerie Buckley +4 more
openaire +2 more sources
Eravacycline for the treatment of intra-abdominal infections
Expert Opinion on Investigational Drugs, 2014There has been a dramatic increase in the incidence of multidrug-resistant pathogens over the past few years, which highlights the need for new anti-infective therapeutics. Eravacycline is a novel, broad-spectrum synthetic tetracycline indicated for the treatment of severe infections caused by Gram-positive and Gram-negative bacteria.In this review ...
Bassetti M., Righi E.
openaire +4 more sources
Eravacycline for the treatment of complicated intra-abdominal infections
Expert Review of Anti-infective Therapy, 2019Introduction: Complicated intra-abdominal infections (cIAIs) are among the most frequent infections, contributing to significant morbidity and healthcare costs. Several medical needs remain unmet, related to the pharmacokinetic capacities of the available drugs and their limited spectrum of activity for targeting multidrug-resistant Gram-negative and ...
Philippe, Montravers +2 more
openaire +2 more sources
Eravacycline for the treatment of patients with bacterial infections
Drugs of Today, 2018Eravacycline is a novel, broad-spectrum, synthetic fluorocycline antibiotic for the treatment of complicated urinary tract infection (cUTI) and complicated intra-abdominal infection (cIAI) due to multidrug-resistant Gram-positive, Gram-negative and anaerobic bacteria that has demonstrated superior potency to that of currently marketed antibiotics ...
R, Thakare, A, Dasgupta, S, Chopra
openaire +2 more sources